Are Options Traders Bullish on ADAP?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon
Adaptimmune Therapeutics PLC American...

ADAP

11.71

-0.26

-2.2%

After Hours:

11.71

0.00

0.0%

Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

Stock Price
Open: 11.95
Prev. Close: 11.97
Low/Hi: 11.64 - 12.06
52-Week: 6.60 - 14.63
Volumes
Equity: 272,198
90-Day Avg: 415,305
Option: 174
90-Day Avg: 248
Volatility
Todays Stock Vol: 32.4
20-Day (HV): 68.4
52-Week (HV): 63.6
30-Day IV: 101.4 +7.3
IV Pct Rank: 99% Elevated
Fundamental
Div. Yield:
Earnings: 6-Nov (Est.)
P/E Ratio:
Market Cap: 1.3 B
Short Int Pct: 0.0%
Pct Held By Inst.: 57.6%
Stock Info
Type: Common
ADR:
Sector: Healthcare
Industry: Biotechnology

About ADAP

Adaptimmune is a clinical stage biopharmaceutical company focused on novel cancer immunotherapy products based on its T-cell receptor platform. Established in 2008, the Company aims to utilize the bodys own machinery - the T-cell - to target and destroy cancer cells by using engineered, increased affinity T-cell receptors (TCRs) as a means of strengthening natural patient T-cell responses. Adaptimmunes lead program is an affinity enhanced TCR therapeutic targeting the NY-ESO cancer antigen. Its NY-ESO TCR therapeutic candidate has demonstrated signs of efficacy and tolerability in Phase 1/2 trials in solid tumors and in hematologic cancer types. As of June 30, 2015, 85 patients had been treated with Adaptimmunes NY-ESO TCR therapeutic: 47 under Adaptimmunes IND, and 38 under a National Cancer Institute IND. In June 2014, Adaptimmune announced that it had entered into a strategic collaboration and licensing agreement with GlaxoSmithKline for the development and commercialization of the NY-ESO TCR program. The Company currently has over 150 employees.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ADAP is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
UBIO Proshares UltraPro Nasdaq Biotechnology 35.3 M 3.52545E+07 196 196 0.02% 0.00019116 22 K 22444
ADRD Invesco BLDRS Developed Markets 100 ADR Index Fund 58.0 M 5.8E+07 87 87 0.02% 0.00017 10 K 9653
ADRU Invesco BLDRS Europe Select ADR Index Fund 14.4 M 1.44E+07 75 75 0.02% 0.0002 3 K 3111
BIB ProShares Ultra Nasdaq Biotechnology 377.2 M 3.7725E+08 202 202 0.03% 0.000334963 280 K 280218
IBB iShares Nasdaq Biotechnology Index Fund 9.4 B 9.4328E+09 191 191 0.09% 0.0009 8.8 M 8807330

Wait, Before You Leave...